What are the guidelines for dyslipidemia?

The CCS guidelines recommend the following lipid targets:

• For high- and intermediate-risk individuals: LDL-C level ≤2.0 mmol/L or a ≥50% reduction from baseline. Alternate treatment targets include apoB ≤0.8 g/L or non-HDL-C ≤2.6 mmol/L.
• For low-risk individuals, a reduction in LDL-C ≥50% from baseline is recommended.

What is first-line treatment for dyslipidemia?

Because of their once-a-day dosing, minimal side effects, and efficacy, the statins are considered a first-line drug therapy for dyslipidemias. The fibrates work preferentially on the liver to reduce triglyceride synthesis and very low-density lipoprotein (VLDL) production.

When Should statins be started?

For primary prevention of CVD, high-intensity statin treatment (atorvastatin 20 mg daily) should be offered to people: Aged 84 years and younger if their estimated 10-year risk of developing CVD using the QRISK assessment tool is 10% or more.

What should a 69 year old woman’s cholesterol be?

So what are your target numbers? According to Michos, an ideal LDL cholesterol level should be less than 70 mg/dl, and a woman’s HDL cholesterol level ideally should be close to 50 mg/dl. Triglycerides should be less than 150 mg/dl. As Michos notes, total cholesterol levels well below 200 mg/dl are best.

What are the ESC 2019 guidelines on dyslipidaemias?

2019 Guidelines on Dyslipidaemias (Management of) ESC Clinical Practice Guidelines. These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.

Why “Table 3” in the new European dyslipidemia guidelines?

But it looks like this reader’s perception has finally been acknowledged, hence “table 3” in the new European dyslipidemia guidelines, where the new recommendations, the amends to the 2016 recommendations, the new sections and the new, or recently revised concepts, are enumerated. A perfect summary to refresh and update all we already knew.

What is the primary target of therapy for dyslipidaemia?

Treatment targets of dyslipidaemia are primarily based on results from clinical trials. In nearly all lipid-lowering trials the LDL-C level has been used as an indicator of response to therapy. There- fore, LDL-C remains the primary target of therapy in most strat- egies of dyslipidaemia management.

What do the new ESC/EAS guidelines on lipids mean for US?

These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.